We propose that plasma miR-141 may represent a novel biomarker thatcomplements CEA in detecting colon cancer with distant metastasis and thathigh levels of miR-141 in plasma were associated with poor prognosis. The gene discussed is CEACAM5; the disease is colonic neoplasm.